The downgrade is a result of several factors, including CHS’s high leverage and weakening operating results since the acquisition of Health Management Associates in 2014. In addition, Fitch acknowledged the execution risks associated with CHS’s divestiture and repositioning plan and that CHS’s hospital portfolio is exposed to smaller, rural markets, which may result in a decline of acute patient volumes.
More articles on healthcare finance:
10 hospitals seeking RCM talent
Microwize Technology releases RCM services
Kentucky hospital at risk of losing Medicare funding
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
